Hikma Pharmaceuticals Llc

This study gives a small group of people with acute myeloid leukemia (AML) continued access to an oral azacitidine tablet after they finished an earlier study. The main goal is to track any side effects and see how safe the drug is over time. About 20 participants will take the t…